Bell Potter recently valued Immutep as buy rating and thinks this biotechnologycompany could be a great option for investors with a high tolerance for currently has a speculative buy rating and 80 cents price target. A couple trials of IMM are phase 2 and 3.
while why not Imugene? The main issue of IMU, too early stage for current trials on phase 1 or 2. Her-vaxx supposed to be phase 2-3 to be successful while disappear? Can’t hold on it to say it.
Bell Potter recently valued Immutep as buy rating and thinks...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $378.4M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.1¢ | $480.3K | 9.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 2298217 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1301664 | 13 |
View Market Depth
| Last trade - 12.10pm 31/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |